Cytodyn Inc
OTC:CYDY
Cytodyn Inc
OTC:CYDY
Price:
0.165 USD
-1.84%
Market Closed
Updated:
May 16, 2024
Balance Sheet
Balance Sheet Decomposition
Cytodyn Inc
Cytodyn Inc
| Current Assets | 8.8m |
| Cash & Short-Term Investments | 147k |
| Other Current Assets | 8.7m |
| Non-Current Assets | 400k |
| PP&E | 332k |
| Other Non-Current Assets | 68k |
| Current Liabilities | 123.4m |
| Accounts Payable | 62.3m |
| Accrued Liabilities | 28.1m |
| Other Current Liabilities | 32.9m |
| Non-Current Liabilities | 211k |
| Other Non-Current Liabilities | 211k |
Balance Sheet
Cytodyn Inc
Cytodyn Inc
Currency: USD
| May-2014 | May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5
|
1
|
10
|
2
|
1
|
3
|
14
|
34
|
4
|
3
|
|
| Cash |
5
|
1
|
10
|
2
|
1
|
3
|
14
|
34
|
4
|
3
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
93
|
18
|
0
|
|
| Other Current Assets |
1
|
1
|
2
|
4
|
2
|
3
|
3
|
2
|
6
|
8
|
|
| Total Current Assets |
5
|
2
|
11
|
6
|
3
|
5
|
37
|
130
|
28
|
11
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Intangible Assets |
3
|
3
|
2
|
2
|
2
|
15
|
13
|
2
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
5
-44%
|
14
+195%
|
8
-42%
|
5
-39%
|
21
+326%
|
51
+142%
|
132
+161%
|
29
-78%
|
11
-61%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
5
|
2
|
4
|
16
|
16
|
29
|
66
|
68
|
63
|
|
| Accrued Liabilities |
1
|
2
|
1
|
1
|
1
|
2
|
8
|
24
|
19
|
23
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
0
|
1
|
0
|
4
|
7
|
63
|
36
|
34
|
|
| Other Current Liabilities |
0
|
3
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
11
|
4
|
6
|
17
|
27
|
45
|
153
|
123
|
120
|
|
| Long-Term Debt |
2
|
3
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
2
|
0
|
3
|
1
|
2
|
0
|
1
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
15
+241%
|
4
-77%
|
9
+156%
|
18
+97%
|
30
+65%
|
53
+78%
|
153
+189%
|
124
-19%
|
121
-2%
|
|
| Equity | |||||||||||
| Common Stock |
31
|
36
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
46
|
72
|
97
|
123
|
173
|
229
|
355
|
511
|
766
|
842
|
|
| Additional Paid In Capital |
20
|
25
|
107
|
122
|
160
|
220
|
352
|
490
|
671
|
731
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
11
N/A
|
10
N/A
|
1
N/A
|
13
-1 093%
|
9
+32%
|
2
+72%
|
21
-747%
|
94
-349%
|
110
-16%
|
|
| Total Liabilities & Equity |
8
N/A
|
5
-44%
|
14
+195%
|
8
-42%
|
5
-39%
|
21
+326%
|
51
+142%
|
132
+161%
|
29
-78%
|
11
-61%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
56
|
64
|
123
|
149
|
217
|
329
|
519
|
626
|
720
|
919
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
